This company has been marked as potentially delisted and may not be actively trading. Cyanotech (CYAN) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsEarningsHeadlinesInsider TradesShort InterestTrendsBuy This Stock CYAN vs. HAPP, BON, SMFL, BFRG, CARM, CSCI, TNON, GOVX, BRTX, and LYRAShould you be buying Cyanotech stock or one of its competitors? The main competitors of Cyanotech include Happiness Development Group (HAPP), Bon Natural Life (BON), Smart for Life (SMFL), Bullfrog AI (BFRG), Carisma Therapeutics (CARM), COSCIENS Biopharma (CSCI), Tenon Medical (TNON), GeoVax Labs (GOVX), Biorestorative Therapies (BRTX), and Lyra Therapeutics (LYRA). Cyanotech vs. Its Competitors Happiness Development Group Bon Natural Life Smart for Life Bullfrog AI Carisma Therapeutics COSCIENS Biopharma Tenon Medical GeoVax Labs Biorestorative Therapies Lyra Therapeutics Cyanotech (NASDAQ:CYAN) and Happiness Development Group (NASDAQ:HAPP) are both small-cap medicinals & botanicals industry companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, analyst recommendations, valuation, profitability, dividends and risk. Which has more risk and volatility, CYAN or HAPP? Cyanotech has a beta of -0.11, meaning that its share price is 111% less volatile than the S&P 500. Comparatively, Happiness Development Group has a beta of 0.23, meaning that its share price is 77% less volatile than the S&P 500. Which has stronger valuation & earnings, CYAN or HAPP? Cyanotech has higher earnings, but lower revenue than Happiness Development Group. Cyanotech is trading at a lower price-to-earnings ratio than Happiness Development Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCyanotech$23.07M0.09-$5.27M-$0.66-0.46Happiness Development Group$95.59M0.06-$49.19M$0.481.60 Is CYAN or HAPP more profitable? Happiness Development Group has a net margin of 0.00% compared to Cyanotech's net margin of -19.50%. Happiness Development Group's return on equity of 0.00% beat Cyanotech's return on equity.Company Net Margins Return on Equity Return on Assets Cyanotech-19.50% -44.71% -19.12% Happiness Development Group N/A N/A N/A Does the media favor CYAN or HAPP? In the previous week, Cyanotech's average media sentiment score of 0.00 equaled Happiness Development Group'saverage media sentiment score. Company Overall Sentiment Cyanotech Neutral Happiness Development Group Neutral Do institutionals and insiders believe in CYAN or HAPP? 24.4% of Cyanotech shares are held by institutional investors. Comparatively, 15.2% of Happiness Development Group shares are held by institutional investors. 29.1% of Cyanotech shares are held by company insiders. Comparatively, 15.6% of Happiness Development Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. SummaryHappiness Development Group beats Cyanotech on 7 of the 11 factors compared between the two stocks. Get Cyanotech News Delivered to You Automatically Sign up to receive the latest news and ratings for CYAN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CYAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CYAN vs. The Competition Export to ExcelMetricCyanotechMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.16M$3.49B$5.72B$9.79BDividend YieldN/AN/A3.91%4.13%P/E Ratio-0.468.4931.1425.06Price / Sales0.0951.51416.9690.94Price / CashN/A5.6236.7858.67Price / Book0.231.169.086.18Net Income-$5.27M$17.44M$3.26B$265.11M Cyanotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CYANCyanotechN/A$0.30flatN/AN/A$2.16M$23.07M-0.4695HAPPHappiness Development GroupN/A$0.71-8.7%N/A-25.3%$4.95M$95.59M1.48215Gap UpBONBon Natural LifeN/A$1.30flatN/A-97.5%$217K$23.84M0.00100Gap DownSMFLSmart for LifeN/A$0.01+138.5%N/A-99.3%$44K$11.11M0.00110Gap UpBFRGBullfrog AI1.3677 of 5 stars$1.28+0.8%N/A-51.4%$11.96MN/A-1.584Positive NewsEarnings ReportCARMCarisma Therapeutics3.1717 of 5 stars$0.28+1.6%$1.93+587.5%-73.9%$11.70M$19.63M-0.1820Short Interest ↓CSCICOSCIENS BiopharmaN/A$3.56-0.6%N/AN/A$11.21M$9.59M-0.6120News CoveragePositive NewsEarnings ReportTNONTenon Medical2.0782 of 5 stars$1.47+6.5%$4.67+217.5%+218.7%$11.16M$3.28M-0.058News CoverageEarnings ReportShort Interest ↑GOVXGeoVax Labs1.8487 of 5 stars$0.70+2.8%$8.88+1,169.7%-89.2%$11.14M$3.95M-0.3510Short Interest ↑BRTXBiorestorative Therapies2.5402 of 5 stars$1.47+4.3%$18.00+1,124.5%-4.4%$11.03M$400K-1.007Earnings ReportAnalyst RevisionLYRALyra Therapeutics3.0182 of 5 stars$6.75+1.2%$100.00+1,381.5%-52.8%$10.80M$1.53M-0.1150News CoverageEarnings ReportAnalyst ForecastAnalyst Revision Related Companies and Tools Related Companies HAPP Competitors BON Competitors SMFL Competitors BFRG Competitors CARM Competitors CSCI Competitors TNON Competitors GOVX Competitors BRTX Competitors LYRA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CYAN) was last updated on 8/17/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyanotech Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyanotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access